L1CAM and ovarian cancer: Fischer et al. used a chimeric anti-L1CAM monoclonal antibody (chCE7) conjugated with 1,4,7,10-tetraazacyclododecane-N-N’-N’-N′′′-tetra acetic acid (DOTA) and labeled with the low-energy β-emitter lutetium-177 (177Lu) to treat human ovarian cancer-bearing mice.